Piitulainen, Eeva <br/><br/>
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.  [electronic resource] 

 -  European journal of clinical pharmacology  Jun 2003 
 - 151-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s00228-003-0589-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Drug Administration Schedule<br/>Female<br/>Half-Life<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Self Administration<br/>Time Factors<br/>alpha 1-Antitrypsin--administration & dosage<br/>alpha 1-Antitrypsin Deficiency--drug therapy